Results 41 to 50 of about 70 (55)
Memantyna w leczeniu zespołów otępiennych [PDF]
, 2015 Wraz ze starzeniem się społeczeństw liczba chorych na zespoły otępienne, w tym chorobę Alzheimera (AD, Alzheimer’s disease) stale się zwiększa. Mimo ogromnej wiedzy na temat patogenezy tych schorzeń nadal nie możemy zaoferować chorym skutecznego leczenia
Narożańska, Ewa, Sławek, Jarosław
core +1 more source
Challenges for treatment of dementia in Alzheimer’s disease
, 2013 The prevalence of dementia is reaching epidemic proportions globally. Alzheimer’s disease (AD) is one of the main causes of dementia. In the absence of a causal cure for AD, symptomatic treatment play a key role in management the disease.
Gabryelewicz, Tomasz, Mandecka, Monika
core
, 2014 Dementia is characterised by a combination of different types of cognitive impairment, which is so significant that it affects daily living, disrupts patients’ professional activity and leads to complete dependence on relatives or adequate institutions ...
Sobów, Tomasz, Wojtera, Marcin
core
Memantine in the treatment of affective disorders
, 2011 The aim of the study was to present the antidepressive and mood-stabilizing properties of memantine, i.e. a drug currently registered for treatment of severe forms of dementia of Alzheimer’s type.
Rabe-Jabłońska, Jolanta +1 more
core
, 2013 Currently available methods of pharmacological treatment of cognitive dysfunction related to Alzheimer’s disease (AD) are based on augmentation of cholinergic neurotransmission (by inhibiting activity of cholinesterases) or modulation of glutamatergic ...
Sobów, Tomasz
core
Pregabalin and duloxetine in the treatment of neuropathic pain : why the use of off-label drugs is consistent with the standards of management and current medical knowledge [PDF]
, 2020 core
Test edukacyjny akredytowany przez Polskie Towarzystwo Neurologiczne [PDF]
, 2012 Redakcja PPN,
core +1 more source